Dietary modification is a first-line, evidence-supported component of multimodal osteoarthritis (OA) management in dogs, with omega-3 fatty acids carrying the strongest evidence base of all nutraceutical interventions. The 2022 AAHA Pain Management Guidelines concluded that omega-3 fatty acids are the only nutraceutical for which the strength of evidence rises above low across a comprehensive review of all supplements evaluated for canine OA.AAHA Clinical G…
Omega-3 fatty acid supplementation produces objective, measurable improvements in weight-bearing. Dogs with OA fed a diet high in fish oil-derived omega-3 fatty acids for 90 days showed improvement in objective weight-bearing assessed by gait analysis.WSAVA Global Gu… Long-chain omega-3 polyunsaturated fatty acids exert synovial anti-inflammatory effects in OA.AAHA Clinical G… In a standardized multimodal protocol for young dogs (9 months–4 years) with radiographically confirmed OA, omega-3 supplementation was initiated at 100 mg/kg/day and increased to 200 mg/kg/day, combined with grapiprant at the recommended daily dose and a graduated leash exercise program targeting 60 minutes daily; client-reported outcome measures improved significantly at every monthly time point over 4 months, and peak vertical force increased significantly from baseline.Frontiers in Ve…
Therapeutic diets formulated for joint health incorporate omega-3 fatty acids, green-lipped mussel (GLM) extract, glucosamine, and chondroitin sulfate as their primary active ingredients. These ingredients have demonstrated anti-inflammatory and chondroprotective effects, with potential adverse effects limited to mild gastrointestinal signs such as diarrhea — a substantially more favorable safety profile than NSAIDs.Journal of the… The combination of chondroitin sulfate, glucosamine, and omega-3 fatty acids has been shown to improve joint status in working dogs assessed by subjective measures.Journal of the… Cats with OA fed a diet enriched with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), GLM extract, and glucosamine/chondroitin sulfate for 9 weeks showed elevated activity levels — though this finding is in cats and should not be directly extrapolated to dogs.WSAVA Global Gu…
Dietary supplements reviewed in canine OA include chondroitin sulfate, glucosamine, undenatured type II collagen, avocado-soybean unsaponifiables, curcumin, and polyunsaturated fatty acids, most of which have demonstrated anticatabolic and anti-inflammatory effects in dogs.Journal of Vete… A diet supplemented with curcuminoids extract, hydrolyzed collagen, and green tea extract has also been evaluated in dogs with OA.BMC Veterinary… Bioavailability of these supplements is generally low, and newer formulations are in development to improve gastrointestinal absorption, though clinical superiority of these formulations over native forms has not yet been established.Journal of Vete…
Weight optimization is the nutritional intervention with the broadest impact across the OA management plan. Caloric restriction prevents obesity, which has a direct positive effect on reducing painful OA and likely decreases pain associated with other conditions.AAHA Clinical G… Obese dogs with canine hip dysplasia are more likely to become clinical at a younger age.Journal of the… NSAID dose should be calculated on the basis of ideal body weight, and short-term or lowest-effective-dose administration mitigates adverse effects on cartilage.Journal of the…
The positioning of dietary modification within the multimodal plan is as a primary, long-term strategy — not an adjunct. NSAIDs and corticosteroids can accelerate cartilage degeneration with long-term use and are associated with gastrointestinal, renal, and hepatic adverse effects.Journal of the…+1 Therapeutic diets and supplements are best framed as the foundation of the long-term plan, with pharmacological agents layered on top at the lowest effective dose for the shortest necessary duration.Journal of the… Weight management, omega-3 supplementation, and NSAID therapy together constitute the interventions with sufficient evidence to support their use in clinical hip OA management.Journal of the…
Would you like guidance on how to select between a commercial therapeutic joint diet versus standalone omega-3 supplementation for a dog already on a maintenance diet?